Stimulation by Bombesin and Inhibition by Bombesin/Gastrin-releasing Peptide Antagonist RC-3095 of Growth of Human Breast Cancer Cell Lines

Tetsu Yano, Jacek Pinski, Kate Groot, Andrew V. Schally

Research output: Contribution to journalArticle

113 Scopus citations


Recently, it was reported that bombesin/gastrin-releasing peptide (GRP) have mitogenic effects on some human breast cancer cell lines. In this study, we investigated the effects of bombesin/GRP and its receptor antagonist (RC-3095) on the proliferation of three breast cancer cell lines, MDA-MB-231, MCF-7 MIII, and MCF-7. Stimulation by bombesin and inhibition by RC-3095 of cell growth were found in MDA-MB-231 and MCF-7 MIII cells cultured in phenol red-free medium with 5% heat-inactivated and dextran-coated charcoal-treated fetal bovine serum (DCC-FBS). A stimulatory effect by bombesin was not observed in the presence of untreated FBS. [3H]Thymidine incorporation into DNA in these cells was suppressed by RC-3095. MCF-7 cells failed to respond to bombesin and RC-3095 in the presence of either FBS or DCC-FBS. GRP-like immunoreactivity was found in the cell extracts and FBS, but it was undetectable in DCC-FBS. It appears that the stimulatory effect of bombesin on cell proliferation of MCF-7 MIII and MDA-MB-231 cell lines could be obtained because of reduction in the levels of some serum factors in DCC-FBS. These results suggest that bombesin/GRP can act as growth factors through bombesin/GRP receptors in some human breast cancers.

Original languageEnglish (US)
Pages (from-to)4545-4547
Number of pages3
JournalCancer Research
Issue number16
StatePublished - Aug 1992


ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this